| Dr J Manuel Zarandona, MD | |
|
5121 Cottonwood St, Intermountain Medical Center Dept. Of Pathology, Murray, UT 84107-5701 | |
| (801) 507-7970 | |
| (801) 507-7996 |
| Full Name | Dr J Manuel Zarandona |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 21 Years |
| Location | 5121 Cottonwood St, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891951091 | NPI | - | NPPES |
| 808368300 | Medicaid | ID | |
| 200246920A | Medicaid | OK | |
| 58089058 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Pathology Services Inc | 1355251521 | 27 |
News Archive
Transfusion of red blood cells (RBCs) stored anaerobically – in the absence of oxygen – is a promising technique to improve resuscitation from hemorrhagic shock, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Research has shown that patients who have had emergency heart attack treatment with heart artery stenting - and have significant narrowings in their other untreated arteries - can benefit from additional stenting to help prevent future heart attacks.
› Verified 7 days ago
| Entity Name | Utah Pathology Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134188998 PECOS PAC ID: 1355251521 Enrollment ID: O20031208000678 |
News Archive
Transfusion of red blood cells (RBCs) stored anaerobically – in the absence of oxygen – is a promising technique to improve resuscitation from hemorrhagic shock, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Research has shown that patients who have had emergency heart attack treatment with heart artery stenting - and have significant narrowings in their other untreated arteries - can benefit from additional stenting to help prevent future heart attacks.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr J Manuel Zarandona, MD 5121 Cottonwood St, Intermountain Medical Center Dept. Of Pathology, Murray, UT 84107-5701 Ph: (801) 507-7970 | Dr J Manuel Zarandona, MD 5121 Cottonwood St, Intermountain Medical Center Dept. Of Pathology, Murray, UT 84107-5701 Ph: (801) 507-7970 |
News Archive
Transfusion of red blood cells (RBCs) stored anaerobically – in the absence of oxygen – is a promising technique to improve resuscitation from hemorrhagic shock, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Research has shown that patients who have had emergency heart attack treatment with heart artery stenting - and have significant narrowings in their other untreated arteries - can benefit from additional stenting to help prevent future heart attacks.
› Verified 7 days ago
Dr. William Dean Wallace, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 747 W 4170 S, Murray, UT 84123 Phone: 801-260-6015 | |
Dr. Michael Thomas Wright, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5770 S 300 E, Murray, UT 84107 Phone: 801-314-2730 Fax: 801-314-2029 | |
Dr. James Richard Farnsworth, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5252 S Intermountain Dr, Murray, UT 84107 Phone: 801-507-2110 Fax: 801-408-5196 | |
Dylan V Miller, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5252 S Intermountain Dr, Murray, UT 84107 Phone: 801-507-2150 Fax: 801-507-2311 |